Buradasınız

CLINICOPATHOLOGICAL STUDY OF ENDOMETRIUM IN IUCD USERS

Journal Name:

Publication Year:

DOI: 
10.5958/j.2319-5886.2.3.072
Abstract (2. Language): 
Background and Aims: Use of intrauterine contraceptive device (IUCD) is now a common practice. The present study was taken up to study the clinicopathological changes in endometrium following use of IUCD. Methods: Endometrium obtained from 65 cases who had IUCD of varying duration, presenting with different symptoms were studied by Hematoxylin and Eosin stained slides. Results: Patients presented with various menstrual irregularities and pelvic inflammatory disease. Duration of IUCD use ranged from 4 months to 10 years. The spectrum of endometrial changes were interstitial edema 22(33.8%), hemorrhage 36(55.3%), focal hyperplasia 18(27.6%), diffuse hyperplasia 2(3%), cystoglandular hyperplasia 4(6.1%), predecidual changes 5(7.6%), inflammatory cell infiltrate 9(13.8%), lymphoid follicles 2(3%), vascular changes 2(3%), metaplasia 1(1.5%). Conclusion: The present study tries to focus on the spectrum of endometrial changes associated with IUCD use, their clinical symptomatology and possible pathogenetic mechanisms. The endometrial changes were possibly due to inflammation, hyperplasia and metaplasia induced by IUCD.
FULL TEXT (PDF): 
412-417

REFERENCES

References: 

1. Margulies L. History of intrauterine devices.
Bull N Y Acad Med.1975;51:662-67.
2. Sujan-Tejuja S, Virick RK, Malkani PK.
Uterine histopathology in the presence of
intra-uterine device. In: Segal SJ, Southam
AL and Shafer KD. Intrauterine
contraception. New York, Excerpta Medica,
1965;86:172-177.
3. Wynn RM: Fine structural effects of
intrauterine contraceptives on the human
endometrium. Fertile Steril.1968;19: 867-
882.
4. Zatuchni GI, Goldsmith A, Shelton JD,
Sciarra JJ. Long acting contraceptive
systems. Philadelphia Harper & Row.1984.
5. Kaufman DW, Shapriro S, Rosenberg
L,Monson RR, Miettinen OS, Stolley PD,
Slone D. Intrauterine contraceptive device
use and pelvic inflammatory disease. Am J
Obster Gynecol.1980 Jan 15;136(2):159-62.
6. Faulkner WL, Ory HW. Intra uterine device
and acute pelvic inflammatory disease.
JAMA.1976; 235: 1851.
7. Hester LL, Kellett WW, Spicer SS
Williamson HO, Pratt-Thomas HR.. Effects
of the intrauterine contraceptive device on
endometrial enzyme and carbohydrate
histochemistry. Am J Obstet Gynecol.1970
Apr 15;106(8):1144-54.
8. Davis HJ, Lesinski J. Mechanism of action of
intrauterine contraceptives in women. Obstet
Gynecol.1970;36(3):350–358.
9. Gonzalez-Angulo A, Aznar-Ramos R.
Ultrastructural studies on the endometrium of
women wearing TCu-200 intrauterine
devices by means of transmission and
scanning electron microscopy and X-ray
dispersive analysis. Am J Obstet
Gynecol.1976;125: 170-179.
10. Tamada T, Okagaki T, Maruyama M,
Matsumoto S. Endometrial histology
associated with an intrauterine contraceptive
device. Am J Obstet Gynecol. 1967;98: 811-
817.
416
Pratima et al., Int J Med Res health Sci. 2013;2(3):412-417
11. Ober WB, Sobrero AJ, DeChabon AB,
Goodman J: Polythelene intrauterine
contraceptive device. Endometrial changes
following long term use. JAMA.1970;212:
765-769.
12. Dallenbach-Hellweg G. Histopathology of
the endometrium, 4th ed. New York:
Springer-Verlag; 1987.
13. Bonney WA, Glasser SR, Clewe TH, Noyes
RW, Cooper CL. Endometrial response to the
intrauterine device. Am J Obstet Gynecol.
14. Lee YB, Kim CS, Ro JY, Kwak HM, Song
CH. Long term effects of IUD on human
endometrium: Histologic, histochemical and
ultrastructural study. Yonsei Med J.1983; 24,
2, 144-148.
15. Fiorino AS: Intrauterine contraceptive device
associated actinomycotic abscess and
Actinomyces detection on cervical smear.
Obstet Gynecol.1996;87:142.
16. Dunn TS, Cothren C, Klein L, Krammer T:
Pelvic actinomycosis. A case report. J
Reprod Med.2006;51:435.

Thank you for copying data from http://www.arastirmax.com